Last Updated: November 8, 2026

POLYSPORIN Drug Patent Profile

Name: POLYSPORIN Drug Patent, Exclusivity, and Generic Launch Dataset
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

When do Polysporin patents expire, and what generic alternatives are available?

Polysporin is a drug marketed by Glaxosmithkline and Monarch Pharms and is included in two NDAs.

The generic ingredient in POLYSPORIN is bacitracin zinc; polymyxin b sulfate. There is one drug master file entry for this compound. Three suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Polysporin

A generic version of POLYSPORIN was approved as bacitracin zinc; polymyxin b sulfate by BAUSCH AND LOMB INC on January 26^th, 1995.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for POLYSPORIN?
What are the global sales for POLYSPORIN?
What is Average Wholesale Price for POLYSPORIN?

Summary for POLYSPORIN

US Patents:	0
Applicants:	2
NDAs:	2
Clinical Trials:	6
DailyMed Link:	POLYSPORIN at DailyMed

Drug patent expirations by year for POLYSPORIN

Recent Clinical Trials for POLYSPORIN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of British Columbia	Phase 2/Phase 3
Stanford University	Phase 2
United Therapeutics	Phase 2

See all POLYSPORIN clinical trials

US Patents and Regulatory Information for POLYSPORIN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Glaxosmithkline	POLYSPORIN	bacitracin zinc; polymyxin b sulfate	AEROSOL;TOPICAL	050167-002	Mar 1, 1985		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Monarch Pharms	POLYSPORIN	bacitracin zinc; polymyxin b sulfate	OINTMENT;OPHTHALMIC	061229-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.